Last reviewed · How we verify
NCT05351255
Motor Learning After Cerebellar Damage: The Role of the Primary Motor Cortex
NA trial testing Transcranial Magnetic Stimulation (TMS) in Cerebellar Ataxia in 17 participants. Participants enrolled and being followed up; not accepting new ones.
19 December 2026
Quick facts
| Lead sponsor | Albert Einstein Healthcare Network |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 17 |
| Start date | 1 July 2022 |
| Primary completion | 19 December 2026 |
| Estimated completion | 19 December 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Transcranial Magnetic Stimulation (TMS)
Conditions studied
- Cerebellar Ataxia — all drugs for Cerebellar Ataxia →
Sponsor
Albert Einstein Healthcare Network
Who can join
Adults 18 to 80, any sex, with Cerebellar Ataxia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will determine (1) whether baseline inhibitory activity in the primary motor cortex can predict motor learning ability in individuals with cerebellar degeneration, and (2) whether modulating primary motor cortex activity with non-invasive brain stimulation alters motor learning ability in this population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05351255
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcranial Magnetic Stimulation (TMS)
Trials testing the same drug.
- NCT05861284 — Developing and Optimizing Transcranial Magnetic Stimulation for Motor Rehabilitation · NA · withdrawn
- NCT07250464 — Motor Evoked Potential and Cortical Silent Period in Migraine · NA · not yet recruiting
- NCT07110493 — Study of Visual Perception Phenomena: Phosphene Mapping Induced by TMS and Its Relationship With Eye Movements · NA · recruiting
- NCT06960083 — Transcranial Magnetic Stimulation in Misophonia · NA · recruiting
- NCT07179406 — The Effect of Spinal Cord Stimulators on Restless Leg Syndrome · NA · recruiting
Other recruiting trials for Cerebellar Ataxia
Currently open trials in the same condition.
- NCT06573866 — Enhancement of Quality of Work And Life · NA · recruiting
- NCT05443906 — Home Exercise for Individuals with Neurodegenerative Disease · NA · recruiting
- NCT05157802 — Promoting Physical Activity Engagement for People With Early-stage Cerebellar Ataxia · Phase 1 · active not recruiting
- NCT03972202 — The Role of Cerebellum in Speech · NA · active not recruiting
- NCT03879018 — Retraining Reaching in Cerebellar Ataxia · NA · recruiting
Other Albert Einstein Healthcare Network trials
Trials by the same sponsor.
- NCT07044323 — Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment · NA · recruiting
- NCT06247904 — NIBS Therapy in Subacute Spinal Cord Injury · NA · enrolling by invitation
- NCT06028334 — GetUp&Go: A Randomized Controlled Trial of an Intervention to Enhance Physical Activity After TBI · NA · recruiting
- NCT04610346 — Assessing an Animal-Assisted Treatment Program for Adults With Aphasia: The Persons With Aphasia Training Dogs Program · NA · completed
- NCT05687994 — Speech Entrainment Treatment for People With Aphasia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05351255 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Albert Einstein Healthcare Network
- Last refreshed: 15 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05351255.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing